Moneycontrol
HomeNewsBusinessStartupCoronavirus pandemic | Startups 3D print ventilator parts, visors to bridge shortfall

Coronavirus pandemic | Startups 3D print ventilator parts, visors to bridge shortfall

Indian startups working with hospitals, doctors to 3D print products and components that can help in capacity expansion for healthcare professionals

March 27, 2020 / 12:41 IST
Story continues below Advertisement

A ventilator is what stands between life and death as coronavirus tightens its grip over the world, with infections inching close to the 535,000-mark and death toll going past 24,000. India has, so far, reported 727 infections and 17 deaths.

As cases tick up in India, ventilators, which are in a short supply, are the biggest worry. If there is community spread, healthcare professionals will have to choose who gets life support and who does not.

Story continues below Advertisement

To help the healthcare sector manage this potential crisis, 3D printing startups are looking at doubling or trebling capacity at hospitals in the quickest possible time.

Bengaluru-based 3D design startup Ethereal Machines is trying to design splitters that can split the airflow from one ventilator and support two patients. But creating such splitters is not easy.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show